References
- Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis 2010;52:347–61
- Rapezzi C, Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, Ferlini A, et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging 2011;38:470–8
- Puille M, Altland K, Linke RP, Steen-Müller MK, Kiett R, Steiner D, Bauer R, et al. 99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy. Eur J Nucl Med Mol Imaging 2002;29:376–9
- Obici L, Franceschini G, Calabresi L, Giorgetti S, Stoppini M, Merlini G, Bellotti V. Structure, function and amyloidogenic propensity of apolipoprotein A-I. Amyloid 2006;13:191–205
- Rowczenio D, Dogan A, Theis JD, Vrana JA, Lachmann HJ, Wechalekar AD, Gilbertson JA, et al. Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. Am J Pathol 2011;179:1978–87
- Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, Ferlini A, et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging 2011;4:659–70
- Kristen AV, Haufe S, Schonland SO, Hegenbart U, Schnabel PA, Röcken C, Hardt S, et al. Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis. Int J Cardiol. 2011. [Epub ahead of print]. doi:10.1016/j.ijcard.2011.06.123
- Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, Salvi F, Ferlini A, et al. Non-invasive identification of senile systemic amyloidosis: incremental diagnostic role of 99mTc-DPD scintigraphy. JACC Cardiovasc Imaging 2012;5:755–8